Filtered By:
Source: Journal of Medical Investigation
Nutrition: Sodium
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 332 results found since Jan 2013.
Long-term empagliflozin therapy improves levels of hepatic fibrosis marker in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus.
Authors: Shinozaki S, Tahara T, Lefor AK, Ogura M
Abstract
The long-term outcomes of patients with non-alcoholic fatty liver disease (NAFLD) treated with sodium-glucose cotransporter-2 inhibitors remain indeterminate. Empagliflozin improves hyperglycemia by increasing glucose excretion in the urine, and it reduces fat volume and insulin resistance. The aim of this study is to assess the effect of long-term empagliflozin therapy on hepatic inflammation, function and fibrosis in patients with NAFLD. This is a two-center retrospective observational study including patients with NAFLD complicated by type 2 diabetes mel...
Source: Journal of Medical Investigation - November 6, 2020 Category: General Medicine Tags: J Med Invest Source Type: research
Clinical characteristics of hyponatremia in patients receiving nutrition support : A cross-sectional study evaluated by bioelectrical impedance analysis
Conclusions : Regardless of sodium intake, higher ECW / TBW was associated with hyponatremia in patients on nutrition support. ECW / TBW may be an important clinical parameter relevant to the nutritional care of hyponatremia. J. Med. Invest. 68 : 112-118, February, 2021.PMID:33994454 | DOI:10.2152/jmi.68.112
Source: Journal of Medical Investigation - May 17, 2021 Category: General Medicine Authors: Mayumi Yano Arisa Inoue Akiyo Toda Michiko Takahashi Makoto Usami Yasuhiro Hamada Source Type: research
